(79 days)
Not Found
No
The summary does not mention AI, ML, or related terms, and the description focuses on computer-assisted navigation based on anatomical landmarks and intraoperative data, which is typical of traditional navigation systems.
No
The device aids the surgeon in bone cuts and implant positioning during joint replacement by providing information, but it does not directly treat or prevent a disease or condition. It is a surgical navigation system, not a therapeutic device.
No
Explanation: The device is described as aiding surgeons with bone cuts and implant positioning during joint replacement by providing information and assisting with surgical instrument placement. It is a computer-assisted surgical navigation system, not a diagnostic device that identifies or characterizes a disease or condition.
No
The device description explicitly states it is a "software-controlled sterotaxic device" and leverages "PiGalileo surgical instruments," indicating the presence of hardware components beyond just software.
Based on the provided information, the Smith & Nephew PiGalileo System TKR is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the examination of specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This typically involves tests performed on blood, urine, tissue, etc., outside of the body.
- PiGalileo System Function: The PiGalileo System is described as a software-controlled stereotaxic device for computer-aided navigation during surgery. Its purpose is to assist the surgeon with bone cuts and implant positioning during the surgical procedure, utilizing intraoperative data and anatomical landmarks.
- Lack of Specimen Examination: The description does not mention the examination of any specimens derived from the human body. The system works directly with the patient's anatomy during surgery.
Therefore, the PiGalileo System falls under the category of a surgical navigation or assistance system, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Smith & Nephew PiGalileo System TKR is intended to be used in computer assisted orthopedic surgery to aid the surgeon with bone cuts and implant positioning during joint replacement. It provides information to the surgeon that is utilized to place surgical instruments during surgery utilizing anatomical landmarks and other data specifically obtained intraoperatively (e.g. ligament tension, limb alignment, etc.)
Examples of some surgical procedures include but are not limited to:
- Total knee replacement supporting bone referencing technique .
- Total knee replacement supporting ligament balancing technique .
- Minimally invasive total knee replacement
Product codes (comma separated list FDA assigned to the subject device)
HAW
Device Description
The PiGalileo Navigation System is a software-controlled sterotaxic device for computer aided navigation of PiGalileo surgical instruments with the purpose of assisting the surgeon in optimally positioning knee and hip prostheses during total knee and hip arthroplasties.
The PiGalileo TKR V2.1 and PiGalileo TKR CAS V4.0 applications are surgical techniques for computer assisted navigation that leverages PiGalileo Total Knee Replacement (TKR) instruments as well as a number of non-navigated knee instruments for total knee replacement with the intent to optimally position knee prostheses during total joint arthroplasty.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
knee, hip
Indicated Patient Age Range
Not Found
Intended User / Care Setting
surgeon
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
ר 222808
Smith & Nephew, Inc. Summary of Safety and Effectiveness PiGalileo TKR V2.1 and PiGalileo TKR CAS V4.0
OCT 2 9 2008
Date of Summary: 07/11/2008
Contact Person and Address
Rishi Sinha Regulatory Affairs Specialist Smith & Nephew, Inc. Orthopaedic Reconstruction 1450 Brooks Road Memphis, TN 38116 (901)399-6054
Name of Device: PiGalileo TKR V2.1 and TKR CAS V4.0 Common Name: PiGalileo TKR
Device Description
The PiGalileo Navigation System is a software-controlled sterotaxic device for computer aided navigation of PiGalileo surgical instruments with the purpose of assisting the surgeon in optimally positioning knee and hip prostheses during total knee and hip arthroplasties.
The PiGalileo TKR V2.1 and PiGalileo TKR CAS V4.0 applications are surgical techniques for computer assisted navigation that leverages PiGalileo Total Knee Replacement (TKR) instruments as well as a number of non-navigated knee instruments for total knee replacement with the intent to optimally position knee prostheses during total joint arthroplasty.
Device Classification
21 CFR 882.4560 Stereotaxic Instrument - Class II
Indications for Use
The Smith & Nephew PiGalileo System TKR is intended to be used in computer assisted orthopedic surgery to aid the surgeon with bone cuts and implant positioning during joint replacement. It provides information to the surgeon that is utilized to place surgical instruments during surgery utilizing anatomical landmarks and other data specifically obtained intraoperatively (e.g. ligament tension, limb alignment, etc.) Examples of some surgical procedures include but are not limited to:
- Total knee replacement supporting bone referencing technique ●
- Total knee replacement supporting ligament balancing technique .
- Minimally invasive total knee replacement .
Substantial Equivalence Information
The overall software design and instruments used with Smith & Nephew PiGalileo TKR CAS V4.0 applications are substantially equivalent to previously cleared device listed below:
| MANUFACTURER | DESCRIPTION | 510(K) | CLEARANCE DATE |
|---|---|---|---|
| PLUS Orthopedics AG | PiGalileo Total Knee | ||
| Replacement (TKR) System | K061362 | 10/06/06 |
1
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird symbol, with three distinct lines forming its body and wings. The bird is positioned within a circular border, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper half of the circle.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Smith & Nephew, Inc. % Rishi Sinha Regulatory Affairs Specialist 1450 Brooks Road Memphis. Tennessee 38116
OCT 2 9 2008
Re: K082267
Trade/Device Name: PiGalileo TKR V2.1 and PiGalileo TKR CAS V4.0 Regulation Number: 21 CFR 882.4560 Regulation Name: Stercotaxic Instrument Regulatory Class: II Product Code: HAW Dated: October 24, 2008 Received: October 29, 2008
Dear Rishi Sinha:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
2
Page 2 - Rishi Sinha
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark M. Milliman
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
KOR2267 510(k) Number (if known):
Device Name: PiGalileo TKR V2.1 and PiGalileo TKR CAS V4.0
Indications for Use:
The Smith & Nephew PiGalileo System TKR is intended to be used in computer assisted orthopedic surgery to aid the surgeon with bone cuts and implant positioning during joint replacement. It provides information to the surgeon that is utilized to place surgical instruments during surgery utilizing anatomical landmarks and other data specifically obtained intraoperatively (e.g. ligament tension, limb alignment, etc.)
Examples of some surgical procedures include but are not limited to:
- Total knee replacement supporting bone referencing technique .
- Total knee replacement supporting ligament balancing technique .
- Minimally invasive total knee replacement �
Prescription Use × (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Deyice Evaluation (ODE)
Mark A. Millikan
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
Page 1 of ____________________________________________________________________________________________________________________________________________________________________
510(k) Number